- Can Current Subclinical Atrial Fibrillation Be Verified by P Wave of 12-Lead ECG at Present? The Answer Already Exists in the Atrial Substrate
-
Shin SY
- KMID: 2545957
- Korean Circ J.
- 2023 Sep;53(9):632-634.
- doi: 10.4070/kcj.2023.0188
-
- CITED
-
- Close
- SHARE
-
- Close
- Simultaneous Transcatheter Treatment for Combined Severe Degenerative Aortic Stenosis and Primary Mitral Regurgitation
-
Lee J, Gossadi M, Kang DY, Ahn JM, Park DW, Kim DH
- KMID: 2545962
- Korean Circ J.
- 2023 Sep;53(9):652-654.
- doi: 10.4070/kcj.2023.0088
-
- CITED
-
- Close
- SHARE
-
- Close
- Should We Use Renin-AngiotensinAldosterone System Inhibitors Routinely in Patients With Hypertrophic Cardiomyopathy?
-
Park JH
- KMID: 2545955
- Korean Circ J.
- 2023 Sep;53(9):619-620.
- doi: 10.4070/kcj.2023.0161
-
- CITED
-
- Close
- SHARE
-
- Close
- Adapting the HEART Pathway for Korean Patients: The Potential Impact on Chest Pain Management at Emergency Department
-
Kim HL
- KMID: 2545959
- Korean Circ J.
- 2023 Sep;53(9):645-647.
- doi: 10.4070/kcj.2023.0165
-
- CITED
-
- Close
- SHARE
-
- Close
- Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
-
Dell’Angela L, Nicolosi GL
- KMID: 2545960
- Korean Circ J.
- 2023 Sep;53(9):648-649.
- doi: 10.4070/kcj.2023.0199
-
- CITED
-
- Close
- SHARE
-
- Close
- Author’s Reply to Cryptogenic Stroke, Patent Foramen Ovale Closure, and Mid to Long-term Outcomes: Rising Shadows of Doubt
-
Lee OH, Kim JS
- KMID: 2545961
- Korean Circ J.
- 2023 Sep;53(9):650-651.
- doi: 10.4070/kcj.2023.1991
-
- CITED
-
- Close
- SHARE
-
- Close
- Coronary Physiology-Based Approaches for Plaque Vulnerability: Implications for Risk Prediction and Treatment Strategies
-
Yang S, Koo BK
- KMID: 2545952
- Korean Circ J.
- 2023 Sep;53(9):581-593.
- doi: 10.4070/kcj.2023.0117
In the catheterization laboratory, the measurement of physiological indexes can help identify functionally significant lesions and has become one of the standard methods to guide treatment decision-making. Plaque vulnerability refers... -
- CITED
-
- Close
- SHARE
-
- Close
- Identifying and Solving Gaps in Preand In-Hospital Acute Myocardial Infarction Care in Asia-Pacific Countries
-
Tern PJW, Vaswani A, Yeo KK
- KMID: 2545953
- Korean Circ J.
- 2023 Sep;53(9):594-605.
- doi: 10.4070/kcj.2023.0169
Acute myocardial infarction (AMI) is a major cause of morbidity and mortality in the Asia-Pacific region, and mortality rates differ between countries in the region. Systems of care have been... -
- CITED
-
- Close
- SHARE
-
- Close
- Modification of HEART Pathway for Patients With Chest Pain: A Korean Perspective
-
Chae B, Ahn S, Kim YJ, Ryoo SM, Sohn CH, Seo DW, Kim WY
- KMID: 2545958
- Korean Circ J.
- 2023 Sep;53(9):635-644.
- doi: 10.4070/kcj.2022.0354
Background and Objectives: The History, Electrocardiography, Age, Risk factors, and Troponin (HEART) pathway was developed to identify patients at low risk of a major adverse cardiac event (MACE) among patients... -
- CITED
-
- Close
- SHARE
-
- Close
- Efficiency of MVP ECG Risk Score for Prediction of Long-Term Atrial Fibrillation in Patients With ICD for Heart Failure With Reduced Ejection Fraction
-
Pay L, Yumurtaş A, Tezen O, Çetin T, Eren S, Çinier G, Hayıroğlu M, Tekkeşin A
- KMID: 2545956
- Korean Circ J.
- 2023 Sep;53(9):621-631.
- doi: 10.4070/kcj.2022.0353
Background and Objectives: The morphology-voltage-P-wave duration (MVP) electrocardiography (ECG) risk score is a newly defined scoring system that has recently been used for atrial fibrillation (AF) prediction. The aim of... -
- CITED
-
- Close
- SHARE
-
- Close
- Prognostic and Safety Implications of Renin-Angiotensin-Aldosterone System Inhibitors in Hypertrophic Cardiomyopathy: A Real-World Observation Over 2,000 Patients
-
Park CS, Rhee TM, Lee HJ, Yoon YE, Park JB, Lee SP, Kim YJ, Cho GY, Hwang IC, Kim HK
- KMID: 2545954
- Korean Circ J.
- 2023 Sep;53(9):606-618.
- doi: 10.4070/kcj.2023.0035
Background and Objectives: The prognostic or safety implication of renin-angiotensinaldosterone system inhibitors (RASi) in hypertrophic cardiomyopathy (HCM) are not well established, mainly due to concerns regarding left ventricular outflow tract... -
- CITED
-
- Close
- SHARE
-
- Close
